These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36157225)

  • 21. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
    Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
    Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.
    Futamura M; Nagao Y; Ishihara K; Takeuchi M; Nakada T; Kawaguchi Y; Asano M; Kumazawa I; Shiroko T; Morimitsu K; Mori R; Nawa M; Shimokawa T; Yoshida K
    Breast Cancer; 2017 Jul; 24(4):615-623. PubMed ID: 28050738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secreted Protein Acidic and Rich in Cysteine (
    Arqueros C; Salazar J; Gallardo A; Andrés M; Tibau A; Lidia Bell O; Artigas A; Lasa A; Ramón Y Cajal T; Lerma E; Barnadas A
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.
    Azim HA; Singhal S; Ignatiadis M; Desmedt C; Fumagalli D; Veys I; Larsimont D; Piccart M; Michiels S; Sotiriou C
    PLoS One; 2013; 8(4):e62451. PubMed ID: 23638089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models.
    Park CR; Jo JH; Song MG; Park JY; Kim YH; Youn H; Paek SH; Chung JK; Jeong JM; Lee YS; Kang KW
    Theranostics; 2019; 9(24):7447-7457. PubMed ID: 31695779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer.
    Guo Q; Zhang H; Li X; Quan X
    Biomed Res Int; 2022; 2022():9430952. PubMed ID: 36147633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of weekly intravenous nanoparticle albumin-bound paclitaxel for non-small cell lung cancer patients who have failed at least two prior systemic treatments.
    Duan J; Hao Y; Wan R; Yu S; Bai H; An T; Zhao J; Wang Z; Zhuo M; Wang J
    Thorac Cancer; 2017 May; 8(3):138-146. PubMed ID: 28304139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
    Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
    Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC.
    Yuan S; Xu J; Zhou B; Zhou Y; Lang M; Cao J; Liu Z; Yang S; Gao S; Hao J
    Int J Biol Sci; 2022; 18(3):911-922. PubMed ID: 35173526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer.
    Komiya K; Nakamura T; Nakashima C; Takahashi K; Umeguchi H; Watanabe N; Sato A; Takeda Y; Kimura S; Sueoka-Aragane N
    Onco Targets Ther; 2016; 9():6663-6668. PubMed ID: 27822069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Prognostic Role of
    Fabrizio FP; Sparaneo A; Fontana A; Mazza T; Graziano P; Pantalone A; Parente P; Centra F; Orlando N; Trombetta D; Torre A; Ferretti GM; Taurchini M; Micco CMD; Maiello E; Fazio VM; Rossi A; Muscarella LA
    Cells; 2020 Jun; 9(6):. PubMed ID: 32580473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China.
    Xing P; Zhu Y; Shan L; Chen S; Hao X; Li J
    Oncotarget; 2017 Oct; 8(50):87442-87454. PubMed ID: 29152093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.
    Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Chen D
    J Drug Target; 2015 May; 23(4):311-22. PubMed ID: 25539074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
    Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
    Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L; Mao W; Chen Q; Jiang Y; Fan Y
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.
    Bull Phelps SL; Carbon J; Miller A; Castro-Rivera E; Arnold S; Brekken RA; Lea JS
    Am J Obstet Gynecol; 2009 Feb; 200(2):180.e1-7. PubMed ID: 18992864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer.
    Schneeweiss A; Seitz J; Smetanay K; Schuetz F; Jaeger D; Bachinger A; Zorn M; Sinn HP; Marmé F
    Anticancer Res; 2014 Nov; 34(11):6609-15. PubMed ID: 25368265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of abraxane on osteosarcoma xenografts in nude mice and expression of secreted protein, acidic and rich in cysteine.
    Yang Y; Niu X; Zhang Q; Hao L; Ding Y; Xu H
    Am J Med Sci; 2012 Sep; 344(3):199-205. PubMed ID: 22222334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
    Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
    Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.